BioXcel Therapeutics (BTAIQ) Gross Margin (2022 - 2026)
BioXcel Therapeutics (BTAIQ) posted Gross Margin of 87.91% for Q2 2026, up 77.08 percentage points from 10.83% a year earlier and up 125.29 percentage points from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Gross Margin (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at BioXcel Therapeutics was 53.10%, up 197.68 percentage points year-over-year; for FY2025, it was 74.45%, up 69.03 percentage points from FY2024.
- Annual Gross Margin shows a three-year change of -20.21 percentage points (FY2022 to FY2025).
- In prior years, BioXcel Therapeutics' Gross Margin was 5.43% in FY2024 (-3.27 pp), 8.70% in FY2023 (-85.97 pp) and 94.67% in FY2022.
- Quarterly Gross Margin has run from a low of -446.73% in Q3 2024 to a high of 96.22% in Q4 2022 over five years.
- On a year-over-year basis, Gross Margin increased in four of the last eight quarters, with an average year-over-year change of +23.28 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2025, with a gain of 535.50 percentage points; the weakest was Q3 2024, with a drop of 396.58 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was -37.38% (Q1 2026), 87.50% (Q4 2025) and 88.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 87.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.91% |
| Mar 31, 2026 | -37.38% |
| Dec 31, 2025 | 87.50% |
| Sep 30, 2025 | 88.78% |
| Jun 30, 2025 | 10.83% |
| Mar 31, 2025 | 91.67% |
| Dec 31, 2024 | -127.32% |
| Sep 30, 2024 | -446.73% |
| Jun 30, 2024 | 94.38% |
| Mar 31, 2024 | 86.25% |
| Dec 31, 2023 | -89.89% |
| Sep 30, 2023 | -50.15% |
| Jun 30, 2023 | 94.31% |
| Mar 31, 2023 | 95.63% |
| Dec 31, 2022 | 96.22% |
| Sep 30, 2022 | 91.97% |
API Access
BioXcel Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();